Advertisement
American Association of Endocrine Surgeon| Volume 146, ISSUE 6, P1224-1227, December 2009

Prophylactic central compartment dissection in thyroid cancer: A new avenue of debate

  • Ashok R. Shaha
    Correspondence
    Reprint requests: Ashok R. Shaha, MD, FACS, Cornell University Medical College, Professor of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
    Affiliations
    Cornell University Medical College and the Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY
    Search for articles by this author
      The December issue of Surgery traditionally publishes manuscripts presented at the Annual Meeting of the American Association of Endocrine Surgeons. This is one of the best sources of information for endocrine diseases, including nuances in the management of thyroid cancer. In recent years, there has been a paradigm shift in the management issues in thyroid cancer and new issues have been raised with technological advances in evaluating the extent of the disease, both pre-operatively and postoperatively. Our debate used to focus on extent of thyroidectomy in well-differentiated thyroid cancer, namely, total versus less than total thyroidectomy. The contemporary controversial issue mainly centers on the management of neck nodes, both central compartment (level VI) and lateral neck nodes. The American Thyroid Association (ATA) guidelines published in 2006 recommended that central compartment dissection should be considered for papillary carcinoma of the thyroid.
      • Cooper D.S.
      • Doherty G.M.
      • Haugen B.R.
      • Kloos R.T.
      • Lee S.L.
      • et al.
      American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
      Since these guidelines were published, there has been considerable debate in relation to the central compartment. Strong sentiments have been expressed by various authors.
      • White M.L.
      • Gauger P.G.
      • Doherty G.M.
      Central lymph node dissection in differentiated thyroid cancer.
      • Grodski S.
      • Cornford L.
      • Sywak M.
      • Sidhu S.
      • Delbridge L.
      Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
      • Swyak M.
      • Cornford L.
      • Roach P.
      • Stalberg P.
      • Sidhu S.
      • Delbridge L.
      Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
      • Mazzaferri E.L.
      • Doherty G.M.
      • Steward D.L.
      The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.
      I do not think the ATA guidelines committee realized the controversy that would be generated by this statement. What was not appreciated was the risk group definition as an indication for evaluation and gross findings of the central compartment during surgery. The recent revised guidelines, which are expected to be published soon, revisit the issue of prophylactic central compartment dissection. The management of neck nodes and elective nodal dissection at level VI has generated several prospective studies and debates, primarily based on the philosophy of the individual surgeon rather than showing any major outcome advantages. There are 3 excellent papers addressing the issue of central compartment lymph nodes published in this issue of Surgery.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cooper D.S.
        • Doherty G.M.
        • Haugen B.R.
        • Kloos R.T.
        • Lee S.L.
        • et al.
        American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
        Thyroid. 2006; 16: 109-142
        • White M.L.
        • Gauger P.G.
        • Doherty G.M.
        Central lymph node dissection in differentiated thyroid cancer.
        World J Surg. 2007; 31: 895-904
        • Grodski S.
        • Cornford L.
        • Sywak M.
        • Sidhu S.
        • Delbridge L.
        Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
        Aust N Z J Surg. 2007; 77: 203-208
        • Swyak M.
        • Cornford L.
        • Roach P.
        • Stalberg P.
        • Sidhu S.
        • Delbridge L.
        Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
        Surgery. 2006; 140: 1000-1007
        • Mazzaferri E.L.
        • Doherty G.M.
        • Steward D.L.
        The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.
        Thyroid. 2009; 19: 683-689
        • Marshall C.L.
        • Evans D.B.
        • Lee J.E.
        • Perrier N.D.
        • Edeiken B.S.
        • Gardner Grubbs E.
        Routine pre-operative ultrasound for papillary thyroid cancer: effects on cervical recurrence.
        Surgery. 2009; 146: 1063-1072
        • Kouvaraki M.A.
        • Shapiro S.E.
        • Fornage B.D.
        • Edeiken-Monro B.S.
        • Sherman S.I.
        • Vassilopoulou-Sellin R.
        • et al.
        Role of pre-operative ultrasonography in the surgical management of patients with thyroid cancer.
        Surgery. 2003; 134: 946-954
        • Monchik J.M.
        • Caragacianu D.L.
        • Simon C.J.
        • Thomay A.A.
        • Tsai V.
        • Cohen J.
        • Mazzaglia P.J.
        Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?.
        Surgery. 2009; 146: 1182-1187
        • Giles Y.
        • Tunca F.
        • Boztepe H.
        • Alagol F.
        • Terzioglu T.
        • Tezelman S.
        The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
        Surgery. 2009; 146: 1188-1195